Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 28, 2021

SELL
$9.32 - $13.4 $4,669 - $6,713
-501 Closed
0 $0
Q3 2020

Oct 28, 2020

SELL
$12.07 - $15.31 $2,015 - $2,556
-167 Reduced 25.0%
501 $6,000
Q2 2020

Jul 23, 2020

BUY
$10.25 - $16.54 $6,847 - $11,048
668 New
668 $9,000
Q2 2019

Jul 02, 2019

SELL
$10.68 - $14.55 $8,052 - $10,970
-754 Closed
0 $0
Q1 2019

Apr 04, 2019

SELL
$12.54 - $16.12 $9,405 - $12,090
-750 Reduced 49.87%
754 $11,000
Q4 2018

Jan 07, 2019

BUY
$10.06 - $14.87 $2,515 - $3,717
250 Added 19.94%
1,504 $20,000
Q3 2018

Oct 12, 2018

BUY
$6.33 - $13.02 $7,937 - $16,327
1,254 New
1,254 $14,000

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $143M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.